A mid-afternoon puff of a preventer inhaler could be the best way for a person with asthma to keep their symptoms under control, according to a new study. Academics, led by experts from the University ...

In February, the FDA approved the Odactra tablet, a sublingual immunotherapy, to treat house dust mite-induced allergic ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...